Locations:
Search
New research highlights serious risks and the critical need for earlier advance care planning
The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis
How we’re efficiently educating patients and care partners about treatment goals, logistics, risks and benefits
Large NIH-funded investigation is exploring this understudied phenomenon
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors
Genomic study lays groundwork for insights into potential biomarkers and therapeutic strategies
Research combining genomics, database analysis and RNA sequencing suggests possible role for antiviral drug therapy
Guidance on patient selection, safety surveillance, choosing among agents and more
Pairing machine learning with multi-omics revealed potential therapeutic targets
Recognizing this association aids risk assessment before starting novel immunotherapies
Advertisement
Advertisement